Sangamo Therapeutics (SGMO) P/E Ratio
P/E Ratio as of Jul 3, 2025: -1.37
Average-1.33
Median-1.33
Minimum-1.52
Maximum-1.13
-1.37
Past Month-0.14 (11.38%)
The P/E ratio for Sangamo Therapeutics (SGMO) is -1.37 as of Jul 3, 2025. This represents a decrease of -5.52% compared to its 12-month average P/E ratio of -1.45. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Sangamo Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sangamo Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sangamo Therapeutics to industry peers.
Sangamo Therapeutics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sangamo Therapeutics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sangamo Therapeutics to industry peers.
Sangamo Therapeutics (SGMO) P/E Ratio Insights
See Sangamo Therapeutics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Sangamo Therapeutics (SGMO)
Order type
Buy in
Order amount
Est. shares
0 shares
Sangamo Therapeutics (SGMO) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $0.5362 | -1.40 |
| Jun 2, 2025 | $0.4729 | -1.23 |
| May 1, 2025 | $0.7412 | -1.43 |
| Apr 1, 2025 | $0.5701 | -1.10 |
| Mar 3, 2025 | $0.9205 | -1.24 |
| Feb 3, 2025 | $1.17 | -1.57 |
| Jan 2, 2025 | $1.13 | -1.52 |
Sangamo Therapeutics (SGMO) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.37 | 0.00% |
| 2024 | -1.37 | +260.53% |
| 2023 | -0.38 | -85.66% |
| 2022 | -2.65 | -56.41% |
| 2021 | -6.08 | -63.92% |
| 2020 | -16.85 | — |
FAQs About Sangamo Therapeutics (SGMO) P/E ratio
The latest P/E ratio of Sangamo Therapeutics (SGMO) is -1.37, as of Jul 3, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Sangamo Therapeutics’s last 12-month average P/E ratio is -1.45, compared to its current P/E ratio of -1.37. This reflects a decrease of -5.52%.
Sangamo Therapeutics’s current P/E ratio of -1.37 is lower than its last 12-month average P/E of -1.45. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Sangamo Therapeutics’s average P/E ratio over the last 3 years is -1.57. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Sangamo Therapeutics’s average P/E ratio over the last 5 years is -5.04. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.